Aijaz, Ayesha
Li, Matthew
Smith, David
Khong, Danika
LeBlon, Courtney
Fenton, Owen S.
Olabisi, Ronke M.
Libutti, Steven
Tischfield, Jay
Maus, Marcela V. http://orcid.org/0000-0002-7578-0393
Deans, Robert
Barcia, Rita N.
Anderson, Daniel G.
Ritz, Jerome http://orcid.org/0000-0001-5526-4669
Preti, Robert
Parekkadan, Biju
Article History
Received: 31 July 2017
Accepted: 8 May 2018
First Online: 11 June 2018
Competing interests
: A.A., M.L., O.S.F., D.K., M.V.M., J.R., J.T., R.M.O. and S.L. declare no competing interests. D.S., C.L. and R.P. are employees of Hitachi Chemical Advanced Therapeutics Solutions. R.D. owns equity in BlueRock Therapeutics. D.G.A. is a founder and equity shareholder in Siglion Therapeutics. R.N.B. is an employee and equity shareholder of Sentien Biotechnologies, Inc. B.P. is a founder and equity shareholder of Sentien Biotechnologies, Inc.